The short answer
Confirm the valerian species before combining this root product with tramadol. If it is Valeriana officinalis, added drowsiness is a reasonable concern, but the generic root name does not establish that identity.
What this answer covers
Generic root/rhizome identity; species confirmation needed.
- Supplement or preparation
- Radix et Rhizoma Valerianae
- Medication ingredient
- tramadol
The sedating effects can overlap
Tramadol labels warn about serious effects with other CNS depressants. Supplement guidance cautions against combining this herb with sedating substances; that supports a precaution, not a measured pair-specific event rate.
Lack of benefit is not proof of safety
A kava and valerian trial did not establish sleep or anxiety benefit. It did not test tramadol, and its efficacy findings do not exclude additive impairment.
Identify the product and formulation
The generic valerian-root name does not identify a species. Immediate-release and extended-release tramadol have different directions, and no herb dose or short gap is established as safe.
Review co-use and act on impairment
Discuss the product with the prescriber and avoid driving while impaired. Do not adjust tramadol yourself. Slow breathing or unusual difficulty waking requires emergency help.
Evidence and practical considerations
Side effects & toxicity
The current generic root/rhizome identity does not establish Valeriana officinalis. Species-specific sedation evidence cannot validate the original unidentified-product claim; a narrower confirmed-species precaution is retained separately.
- Exact scope
- Generic root/rhizome identity; species confirmation needed. with Tramadol10689 IN; oral hydrochloride IR/ER with active M1 and formulation limits.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No unmeasured pair incidence, blanket class transfer or arbitrary spacing interval.
Factors that may matter: Preparation; Dose; Other medicines; Organ function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed tramadol
Parent tramadol and active M1 metabolite contribute effects; CYP2D6 inhibition can raise parent while lowering M1. Serotonin syndrome, seizures and CNS-depressant risks.
How this applies: Exact tramadol RxCUI 10689 IN, with stated salt/formulation/route bridge.
Not interchangeable with extended-release dosing or combination products; no botanical-specific incidence.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed tramadol
CYP3A induction including St John’s wort can alter tramadol exposure; serotonergic and CNS-depressant precautions.
How this applies: Exact tramadol RxCUI 10689 IN, with stated salt/formulation/route bridge.
Once-daily formulation-specific directions and restrictions; not an immediate-release or injectable regimen.
Source 3: federal supplement safety guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: Users of the specified supplement.
Possible but unproven sleep-inducing effects; advises against combining valerian with alcohol or sedatives.
How this applies: Original source interpreted for tramadol only within the stated preparation and endpoint limits.
Not a direct tramadol combination trial; original preparation, dose and endpoint limits apply. No exact-pair adverse-event rate or protective spacing established.
Source 4: federal botanical identity and safety guidance
ods.od.nih.gov · Source check Sep 10, 2026
Population: Users of Valeriana officinalis.
The fact sheet covers only V. officinalis among more than 250 valerian species; possible additive sedation is theoretical.
How this applies: Original source interpreted for tramadol only within the stated preparation and endpoint limits.
Not a direct tramadol combination trial; original preparation, dose and endpoint limits apply. No exact-pair adverse-event rate or protective spacing established.
Source 5: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 391 participants with anxiety and insomnia.
Neither botanical improved its primary anxiety/insomnia outcome over placebo.
How this applies: Original source interpreted for tramadol only within the stated preparation and endpoint limits.
Not a direct tramadol combination trial; original preparation, dose and endpoint limits apply. No exact-pair adverse-event rate or protective spacing established.
Research assessment: · Open full citations ↗
Side effects & toxicity
If the product is confirmed as Valeriana officinalis, additive drowsiness with tramadol is a conditional concern based on medication labeling and species-specific guidance.
- Exact scope
- Confirmed Valeriana officinalis root preparation, not an unidentified generic valerian root. with Exact tramadol ingredient and labeled formulations described in this article.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No exact-pair event rate or protective interval established.
Factors that may matter: Confirmed botanical identity; Preparation; Dose; Other sedatives.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed tramadol
Parent tramadol and active M1 metabolite contribute effects; CYP2D6 inhibition can raise parent while lowering M1. Serotonin syndrome, seizures and CNS-depressant risks.
How this applies: Exact tramadol RxCUI 10689 IN, with stated salt/formulation/route bridge.
Not interchangeable with extended-release dosing or combination products; no botanical-specific incidence.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed tramadol
CYP3A induction including St John’s wort can alter tramadol exposure; serotonergic and CNS-depressant precautions.
How this applies: Exact tramadol RxCUI 10689 IN, with stated salt/formulation/route bridge.
Once-daily formulation-specific directions and restrictions; not an immediate-release or injectable regimen.
Source 3: federal supplement safety guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: Users of the specified supplement.
Possible but unproven sleep-inducing effects; advises against combining valerian with alcohol or sedatives.
How this applies: Original source interpreted for tramadol only within the stated preparation and endpoint limits.
Not a direct tramadol combination trial; original preparation, dose and endpoint limits apply. No exact-pair adverse-event rate or protective spacing established.
Source 4: federal botanical identity and safety guidance
ods.od.nih.gov · Source check Sep 10, 2026
Population: Users of Valeriana officinalis.
The fact sheet covers only V. officinalis among more than 250 valerian species; possible additive sedation is theoretical.
How this applies: Original source interpreted for tramadol only within the stated preparation and endpoint limits.
Not a direct tramadol combination trial; original preparation, dose and endpoint limits apply. No exact-pair adverse-event rate or protective spacing established.
Source 5: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 391 participants with anxiety and insomnia.
Neither botanical improved its primary anxiety/insomnia outcome over placebo.
How this applies: Original source interpreted for tramadol only within the stated preparation and endpoint limits.
Not a direct tramadol combination trial; original preparation, dose and endpoint limits apply. No exact-pair adverse-event rate or protective spacing established.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact tramadol article with formulation-specific evidence and uncertainty. | |
| Research summary published |
Article revision: bf03bc466168589a
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.